Stable Angina Pectoris Clinical Trials

7 recruitingLast updated: May 21, 2026

There are 7 actively recruiting stable angina pectoris clinical trials across 7 countries. Studies span Phase 4, Not Applicable, Phase 3. Top locations include Alicante, Alicante, Spain, Bologna, Emilia-Romagna, Italy, Copenhagen, Denmark. Updated daily from ClinicalTrials.gov.


Stable Angina Pectoris Trials at a Glance

7 actively recruiting trials for stable angina pectoris are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 4 with 2 trials, with the heaviest enrollment activity in Alicante, Bologna, and Copenhagen. Lead sponsors running stable angina pectoris studies include Instituto de Investigación Sanitaria y Biomédica de Alicante, Takeshi Morimoto, and Clinical Center Niš.

Browse stable angina pectoris trials by phase

About Stable Angina Pectoris Clinical Trials

Looking for clinical trials for Stable Angina Pectoris? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stable Angina Pectoris trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stable Angina Pectoris clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome

Unstable Angina PectorisST Elevation (STEMI) Myocardial InfarctionNon ST Elevation Myocardial Infarction (NSTEMI)
Clinical Center Niš550 enrolled1 locationNCT07366684
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Cardiorespiratory FitnessAcute Myocardial InfarctionAngina, Stable+3 more
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275
Recruiting

TTE Improves Clinical Management of Stable Chest Pain

Stable Angina PectorisCoronary Artery DiseaseMajor Adverse Cardiac Events+2 more
Tianjin Chest Hospital50,000 enrolled1 locationNCT07063147
Recruiting
Phase 4

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

chronic coronary artery diseaseStable Angina PectorisCoronary Artery Disease+3 more
Tina Vilsbøll124 enrolled3 locationsNCT06606821
Recruiting

International Survey of Acute Coronary Syndromes

Coronary DiseaseAcute Coronary SyndromeMyocardial Infarction+1 more
University of Bologna36,000 enrolled1 locationNCT01218776
Recruiting
Phase 3

Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

Chronic Stable Angina Pectoris
Tasly Pharmaceuticals, Inc.765 enrolled1 locationNCT03789552
Recruiting
Phase 4

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

Stable Angina PectorisCoronary Artery DiseaseIschemic Heart Disease
Takeshi Morimoto2,890 enrolled1 locationNCT05347069